Mechanism of Action
RESPIMAT: COMBIVENT RESPIMAT is a combination of the anticholinergic ipratropium bromide and the beta 2 -adrenergic agonist albuterol sulfate. The mechanisms of action described below for the individual components apply to COMBIVENT RESPIMAT. The two classes of medications (an anticholinergic and a…
Indications (2)
Clinical Trials (5)
Ventilator Adapters for Combivent Respimat
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma
Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)
Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.